PMCB Pharmacyte Biotech0.69-0.10 (-12.1%)
PMCB Pharmacyte Biotech1.37+0.16 (+13.2%)
PMCB Pharmacyte Biotech1.22+0.44 (+55.4%)
PMCB Pharmacyte Biotech2.24+0.01 (+0.5%)
PMCB Pharmacyte Biotech2.24+0.09 (+4.2%)
Premarket Gainer
PMCB Pharmacyte Biotech2.20-0.01-0.5%
Premarket:2.72+0.52 (+23.6%)
PharmaCyte Biotech Announces More Positive Tests Results for Its Pancreatic Cancer Clinical Trial Product Candidate to Satisfy FDA Requirements
Business WireTue, 19-Apr 9:00 AM